Seronegative antibody‐mediated neurology after immune checkpoint inhibitors

Checkpoint inhibitor medications have revolutionized oncology practice, but frequently induce immune‐related adverse events. During autoimmune neurology practice over 20 months, we prospectively identified four patients with likely antibody‐mediated neurological diseases after checkpoint inhibitors:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Robert, Menassa, David A., Davies, Alexander J., Michael, Sophia, Hester, Joanna, Kuker, Wilhelm, Collins, Graham P., Cossins, Judith, Beeson, David, Steven, Neil, Maddison, Paul, Rinaldi, Simon, Jacob, Saiju, Irani, Sarosh R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945956/
https://www.ncbi.nlm.nih.gov/pubmed/29761126
http://dx.doi.org/10.1002/acn3.547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945956/
https://www.ncbi.nlm.nih.gov/pubmed/29761126
http://dx.doi.org/10.1002/acn3.547

Ejemplares similares